TOKYO (Reuters) - Philip Morris International Inc a ranar Talata ya ƙaddamar da sigar mai rahusa na "zafin da ba ya ƙone" samfurin IQOS a Japan a yunƙurin farfado da tallace-tallace da kuma guje wa gasa daga sauran hanyoyin sigari na gargajiya.
Tun lokacin da aka hana e-cigare na al'ada da ke ɗauke da ruwan nicotine yadda ya kamata a Japan, ƙasar ta zama babbar kasuwa ga samfuran "duma mai ƙonewa" (HNB), waɗanda ke da ƙarancin hayaki da wari fiye da sigari na gargajiya.
Maƙerin sigari na Marlboro Philip Morris shi ne ya fara sayar da kayayyakin da ke hana wuta a Japan a cikin 2014, amma bayan fara tallace-tallacen da aka yi a shekarar da ta gabata da kuma gasa daga Tabar Baƙin Amurkawa ta Biritaniya da Taba ta Japan, haɓakar kasuwar sa ya tsaya cik a cikin 'yan kwanakin nan...
Shugaban Philip Morris Andrey Calanzopoulos ya shaida wa manema labarai a ranar Talata cewa, tun lokacin da aka kaddamar da IQOS a Japan, "A bayyane yake cewa tallace-tallace na IQOS ya ragu."
Amma ya ce idan ƙarin zaɓi ya sa samfurin ya zama sananne ga masu amfani da shi, to, haɓaka gasa a cikin dogon lokaci ba lallai ba ne.
Sabuwar tarin “HEETS”, wanda farashinsa akan 470 yen ($ 4.18) kowace fakiti, zai kasance ranar Talata, in ji shi.Wannan yana da arha fiye da na Philip Morris HeatSticks na yanzu, waɗanda buhunan sigari ne na na'urorin IQOS, waɗanda ke biyan yen 500 kowace fakiti.
"A bayyane yake yana da tsada ga wasu mutane su kashe karin yen 30 a rana, karin yen 40," Calanzopoulos ya fada wa kamfanin dillancin labarai na Reuters a wata hira ta daban.
A tsakiyar watan Nuwamba, kamfanin zai kuma fitar da ingantattun nau'ikan na'urorin sa na IQOS 3 da IQOS 3 MULTI.Za a ci gaba da kasancewa da sigar da ta kasance a farashin yanzu.
Kwanan nan, IQOS ya sanya haɓaka mai rauni fiye da yadda ake tsammani bayan Philip Morris, kamfani mafi girma a duniya da aka jera tabar sigari, ya zama jagora a duniya kan ɗumama mara wuta.
Philip Morris ya ce IQOS tana rike da kashi 15.5% na kasuwar taba sigari ta Japan, gami da sigari na gargajiya, amma rabon kasuwar ya daidaita.
"Ina tsammanin raguwa a kowane nau'i na halitta ne," in ji Calanzopoulos."Muna da mabiya a baya da kuma mutane masu ra'ayin mazan jiya."
Philip Morris ya kuma shigar da aikace-aikacen tallace-tallace na IQOS tare da FDA, yana bawa kamfanin damar tallata shi da sunan rage haɗari.
An fitar da Philip Morris daga Altria Group Inc. kusan shekaru goma da suka gabata kuma Altria zai tallata IQOS a Amurka.
Calantzopoulos ya ce ana sa ran lasisin kasuwanci a ƙarshen shekara kuma Altria "a shirye take don ƙaddamarwa".
Rahoton na Disamba na Reuters ya nuna gazawa a cikin horo da gogewar wasu manyan masu binciken a cikin gwajin asibiti na Philip Morris da aka gabatar ga FDA.
Philip Morris ya samu kulawa a yau litinin bayan gudanar da wata jarida mai shafuka hudu yana kira ga masu shan taba da su daina.
Lokacin aikawa: Nov-01-2022